FAM190B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.010200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.489010E-01
Normal-vs-Stage2
3.401600E-01
Normal-vs-Stage3
1.589910E-02
Normal-vs-Stage4
7.694800E-01
Stage1-vs-Stage2
6.564800E-01
Stage1-vs-Stage3
2.187200E-01
Stage1-vs-Stage4
3.617400E-01
Stage2-vs-Stage3
2.238400E-04
Stage2-vs-Stage4
5.063200E-01
Stage3-vs-Stage4
1.912170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.771800E-01
Normal-vs-AfricanAmerican
9.712000E-01
Normal-vs-Asian
1.818630E-01
Caucasian-vs-AfricanAmerican
1.476820E-01
Caucasian-vs-Asian
2.881400E-01
AfricanAmerican-vs-Asian
1.139370E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.626400E-01
Normal-vs-Female
3.688000E-01
Male-vs-Female
4.535800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.497800E-02
Normal-vs-Age(41-60Yrs)
6.306000E-01
Normal-vs-Age(61-80Yrs)
2.324400E-01
Normal-vs-Age(81-100Yrs)
1.692320E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.552600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.566800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.920600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.318160E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.800320E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.175770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.889500E-02
Normal-vs-Daily Drinker
3.119500E-02
Normal-vs-Weekly Drinker
2.203800E-01
Normal-vs-Occasional Drinker
4.029200E-01
Normal-vs-Social Drinker
8.933600E-01
Non Drinker-vs-Daily Drinker
6.222400E-01
Non Drinker-vs-Weekly Drinker
6.094600E-01
Non Drinker-vs-Occasional Drinker
1.705610E-01
Non Drinker-vs-Social Drinker
1.205170E-01
Daily Drinker-vs-Weekly Drinker
3.580800E-01
Daily Drinker-vs-Occasional Drinker
7.811700E-02
Daily Drinker-vs-Social Drinker
7.701700E-02
Weekly Drinker-vs-Occasional Drinker
5.113600E-01
Weekly Drinker-vs-Social Drinker
2.401000E-01
Occasional Drinker-vs-Social Drinker
4.538800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.176630E-01
Normal-vs-Grade 2
3.249500E-02
Normal-vs-Grade 3
4.967600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.406020E-01
Grade 1-vs-Grade 3
4.082000E-01
Grade 1-vs-Grade 4
1.176630E-01
Grade 2-vs-Grade 3
5.088200E-01
Grade 2-vs-Grade 4
3.249500E-02
Grade 3-vs-Grade 4
4.967600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.832800E-01
Normal-vs-NonDiabetic
1.958380E-01
Diabetic-vs-NonDiabetic
3.987400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.670600E-01
Normal-vs-NoPancreatitis
2.505200E-01
Pancreatitis-vs-NoPancreatitis
8.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.480200E-01
Normal-vs-N1
3.323400E-01
N0-vs-N1
4.364600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.771200E-01
Normal-vs-TP53-NonMutant
3.894800E-01
TP53-Mutant-vs-TP53-NonMutant
5.386200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
